A rare complication in a case of multiple myeloma on therapy with thalidomide and dexamethasone—Reversible posterior lobe leukoencephalopathy-Reference-Cited by-同舟云学术

A rare complication in a case of multiple myeloma on therapy with thalidomide and dexamethasone—Reversible posterior lobe leukoencephalopathy

Published:2006-01 Issue:7 Volume:47 Page:1431-1434
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Pandey Ritwik,Patel Apurva,Shah Sandip,Patel Kirti M.,Shah Pankaj M.,Shukla Shilin N.,Parikh Bharat J.,Anand Asha,Talati Shailesh S.,Panchal Harsha,Parikh Sonia,Thrutthel Sanjay

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600581815

Reference15 articles.

1. Multiple Myeloma Associated With Progressive Multifocal Leukoencephalopathy

2. Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions

3. Multiple Myeloma

4. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

5. Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posterior reversible encephalopathy syndrome (PRES) and myeloma;Leukemia Research Reports;2024

2. Cyclophosphamide‐induced posterior reversible encephalopathy syndrome: A case report;Neurology and Clinical Neuroscience;2021-06-05

3. Elevation of serum lactate dehydrogenase at posterior reversible encephalopathy syndrome onset in chemotherapy-treated cancer patients;Journal of Clinical Neuroscience;2014-09

4. Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide;Leukemia & Lymphoma;2011-12-06

5. Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs;Internal Medicine Journal;2009-12